Currently, only Rs 3,500 crore (Rs 35 billion) of the Rs 24,280 crore (Rs 242.8 billion) goes to the organised sector. Companies are targeting kids from the age of one to 14. According to Technopak, this sector is growing at 20 per cent per annum.
In a bid to transform Mumbai into a world-class financial hub, the Centre has asked the Maharashtra government to upgrade its ports, railway and other infrastructure at the earliest.
The medicines whose prices have been reduced belong to therapeutic categories, like dexametozone, betamethazone, ampicillin and ranitidine. The prices of some multi-vitamins and antibiotics would rise a bit.
The R&D plan, focused on diseases affecting poor nations, is expected to be ready by 2008 and may benefit Indian drug firms and contract research organisations in a big way.
Over the past one year, since the helpline became functional (on September 8, 2006), a total of 3,110 grievances have been registered.
It is not the urban centres alone that are powering India's phenomenal growth in mobile telephony. Data on rural telephony, compiled by the telecom regulator, shows people in villages are subscribing to mobile services in large numbers
The PhRMA's observation is significant against the backdrop of Swiss pharma major Novartis AG's decision to relocate its R&D investments from India.
The patent department made this declaration on August 16 after Novartis had failed to respond to its queries within the prescribed time.
The profit margins of multinational companies importing medicines into India have been hit with the National Pharmaceutical Pricing Authority starting strict scrutiny of price approval applications for imported products.
Indian exporters of ayurvedic drugs are finding it extremely difficult to tap this high-growth segment
The study was commissioned by the Forum of Indian Regulators -- a body which is open to all regulators but currently dominated by power regulators.
According to a petition filed by Quadrant in the Delhi High Court, Travel Guru allegedly copied its software solution 'Final Quadrant SuiteCase'.
Absence of operational manual that guides examiners, heavy backlog take a toll.
Indian pharmaceutical companies exporting medicines worth $1 billion to at least a dozen countries like Brazil, Mexico, China and Germany are finding non-tariff barriers, in the form of discriminatory treatments, hampering their export prospect.
Besides Novartis, the other companies are Roche, J&J, Glaxo and Astrazeneca.
This has prompted public health groups to call the concerns of Swiss drug major Novartis that inadequacies in Indian patent law will have negative consequences for patients and public health in India as 'bogus'.
After filing their objections against the Air India-Indian Airlines merger with the corporate affairs ministry on August 31, the unions of Indian Airlines are now planning to take the matter to court.
Thursday's flooding of the National Informatics Centre rendered most of the Indian government websites with the domain address 'nic.in' -- including the Prime Minister's and President's websites -- inaccessible.
The central government is considering an expansion of the list of fertilisers that are eligible for subsidy.
Rs 35,000 crore investment to increase capacity by 75%.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances